Talyst acquired by Swisslog Healthcare
Swisslog Healthcare has bought West Coast medication management company Talyst. Starting in 2018, the companies will begin integrating their pharmacy systems to address a large customer base in North America.
Talyst CEO Carla Corkern will not join the new company, according to published reports. However, the vast majority of Talyst employees will be brought into Swisslog North America, executives told McKnight's.
Swisslog, which has headquarters in Denver, will retain its building and facility in Kirkland, WA, and integrate the Dallas Talyst office into its own office there, according to Stead Broadwell, a board member and managing director of Columbia Pacific Advisors.
He said the strategic deal made sense given how Swisslog Healthcare “is a global leader in healthcare and software systems design.”
“There are two important trends that are happening that Swisslog can take advantage of. One is in skilled nursing and the increasing recognition of high-acute facilities that need advanced automation solutions to improve patient care. Talyst Insite Care is scaling nicely because there has become broader regulatory approval,” Broadwell said.
Terms of the deal were not disclosed.